Tacrine is a reversible acetylcholinesterase inhibitor of the acridine class, historically indicated for the symptomatic treatment of mild to moderate Alzheimer’s disease to improve cognitive function… Read more
Tacrine is a reversible acetylcholinesterase inhibitor of the acridine class, historically indicated for the symptomatic treatment of mild to moderate Alzheimer’s disease to improve cognitive function by increasing synaptic acetylcholine levels. Laboratories involved in pharmaceutical research and quality control utilize this collection of reference standards, including the active metabolite 1-hydroxy tacrine and its stable isotope labelled derivatives, to ensure accurate analytical testing. These compounds are essential for impurity profiling, allowing researchers to detect and quantify trace impurities during method validation and stability studies. The availability of high-quality deuterated internal standards, such as 1-hydroxy tacrine-d4, facilitates precise mass spectrometry-based quantification, supporting critical metabolite identification and the overall evaluation of pharmacokinetic profiles in both clinical and bioanalytical investigations of the parent compound.